Google DeepMind
Search results
home. about us. our approach. life at iso. work with us. news. © 2022 ISOMORPHIC LABS. Welcome toIsomorphic Labs. 0. a--up. none. 1. a--up. none. We’re a digital biology company, here to redefine drug discovery with the power of artificial intelligence. 2. a--up. a--h-150-100. 0.
- about us
a--up. none. Isomorphic Labs was born in 2021 to apply AI...
- our approach
The traditional process of drug discovery is too long, too...
- life at iso
A commitment to a shared goal. We know we’ll get where we’re...
- work with us
For jobs in London, yes. We can help with visa applications...
- news
Why I: Isomorphic Labs colleagues share what attracted them...
- Terms & Conditions
Isomorphic Labs Limited, is a company organised under the...
- about us
Isomorphic Labs Limited is a London-based company which uses artificial intelligence for drug discovery. Isomorphic Labs was founded by Demis Hassabis, who also serves the CEO. The company was incorporated on February 4, 2021 and announced on November 5, 2021.
What’s next for Isomorphic Labs. This is just the beginning of what we hope will become a radical new approach to drug discovery, and I’m incredibly excited to get this ambitious new commercial venture off the ground and to partner with pharmaceutical and biomedical companies.
May 8, 2024 · May 08, 2024. 6 min read. Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery. Google DeepMind AlphaFold team.
Jan 7, 2024 · Isomorphic Labs announces strategic collaborations with two of the world’s leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be worth nearly $3 billion to Isomorphic Labs, excluding any royalties that may result from future drug sales, and are testament to Isomorphic’s approach to ...
